Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
440.64
+3.15 (0.72%)
At close: May 16, 2024, 4:00 PM
440.00
-0.64 (-0.15%)
After-hours: May 16, 2024, 4:56 PM EDT
Vertex Pharmaceuticals Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for VRTX stock have an average target of 441.4, with a low estimate of 364 and a high estimate of 559. The average target predicts an increase of 0.17% from the current stock price of 440.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for VRTX stock from 25 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 7 | 6 |
| Buy | 13 | 13 | 11 | 11 | 12 | 12 |
| Hold | 7 | 6 | 7 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 27 | 28 | 27 | 27 | 26 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $417 → $424 | Hold | Maintains | $417 → $424 | -3.78% | May 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $450 → $456 | Buy | Maintains | $450 → $456 | +3.49% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $462 | Strong Buy | Reiterates | $462 | +4.85% | May 7, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $445 → $450 | Strong Buy | Maintains | $445 → $450 | +2.12% | Apr 18, 2024 |
Financial Forecast
Revenue This Year
10.93B
from 9.87B
Increased by 10.73%
Revenue Next Year
11.95B
from 10.93B
Increased by 9.36%
EPS This Year
17.11
from 13.89
Increased by 23.21%
EPS Next Year
18.72
from 17.11
Increased by 9.38%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.5B | 13.8B | 15.2B | 16.6B | 18.7B |
| Avg | 10.9B | 12.0B | 13.1B | 14.3B | 15.8B |
| Low | 10.4B | 10.7B | 11.5B | 12.1B | 12.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.8% | 26.0% | 27.3% | 26.1% | 30.6% |
| Avg | 10.7% | 9.4% | 10.0% | 9.0% | 10.1% |
| Low | 5.2% | -1.9% | -3.9% | -8.3% | -9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.20 | 21.79 | 26.81 | 27.70 | 32.31 |
| Avg | 17.11 | 18.72 | 20.93 | 22.08 | 24.60 |
| Low | 14.85 | 14.29 | 16.45 | 17.78 | 19.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.3% | 27.3% | 43.2% | 32.4% | 46.3% |
| Avg | 23.2% | 9.4% | 11.8% | 5.5% | 11.4% |
| Low | 6.9% | -16.5% | -12.1% | -15.0% | -11.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.